Medpace Holdings Future Growth
Future criteria checks 3/6
Medpace Holdings is forecast to grow earnings and revenue by 13.6% and 12.6% per annum respectively. EPS is expected to grow by 13% per annum. Return on equity is forecast to be 30.2% in 3 years.
Key information
13.6%
Earnings growth rate
13.0%
EPS growth rate
| Life Sciences earnings growth | 17.7% |
| Revenue growth rate | 12.6% |
| Future return on equity | 30.2% |
| Analyst coverage | Good |
| Last updated | 30 Aug 2024 |
Recent future growth updates
Recent updates
Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Sep 02
Medpace: Continued Business Growth With Asymmetrical Payoff Opportunity
Aug 20Why Medpace Holdings' (NASDAQ:MEDP) Earnings Are Better Than They Seem
Jul 31Medpace Holdings, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Jul 25What You Can Learn From Medpace Holdings, Inc.'s (NASDAQ:MEDP) P/E
Jun 18Medpace: Clear Winner If China Blockade Succeeds
Jun 04A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
May 22Does Medpace Holdings (NASDAQ:MEDP) Deserve A Spot On Your Watchlist?
Apr 12Medpace: Exceptional Performance, Almost Fully Priced In
Mar 11Medpace Holdings, Inc.'s (NASDAQ:MEDP) 32% Jump Shows Its Popularity With Investors
Feb 18Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Feb 09A Look At The Intrinsic Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jan 25Should You Be Adding Medpace Holdings (NASDAQ:MEDP) To Your Watchlist Today?
Jan 10Shareholders Should Be Pleased With Medpace Holdings, Inc.'s (NASDAQ:MEDP) Price
Dec 26Should You Investigate Medpace Holdings, Inc. (NASDAQ:MEDP) At US$275?
Nov 08Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 29% Below Their Intrinsic Value Estimate
Oct 23If EPS Growth Is Important To You, Medpace Holdings (NASDAQ:MEDP) Presents An Opportunity
Oct 10Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Aug 27Should You Think About Buying Medpace Holdings, Inc. (NASDAQ:MEDP) Now?
Jul 31A Look At The Fair Value Of Medpace Holdings, Inc. (NASDAQ:MEDP)
Jul 18Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Jul 04Is Medpace Holdings (NASDAQ:MEDP) A Risky Investment?
May 25Is Now The Time To Look At Buying Medpace Holdings, Inc. (NASDAQ:MEDP)?
Apr 27An Intrinsic Calculation For Medpace Holdings, Inc. (NASDAQ:MEDP) Suggests It's 28% Undervalued
Apr 12We Ran A Stock Scan For Earnings Growth And Medpace Holdings (NASDAQ:MEDP) Passed With Ease
Mar 27Does Medpace Holdings (NASDAQ:MEDP) Have A Healthy Balance Sheet?
Feb 14What Is Medpace Holdings, Inc.'s (NASDAQ:MEDP) Share Price Doing?
Jan 16Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 41% Below Their Intrinsic Value Estimate
Jan 03Here's Why We Think Medpace Holdings (NASDAQ:MEDP) Might Deserve Your Attention Today
Dec 20Medpace Holdings (NASDAQ:MEDP) Has A Rock Solid Balance Sheet
Nov 16Growth Investors: Industry Analysts Just Upgraded Their Medpace Holdings, Inc. (NASDAQ:MEDP) Revenue Forecasts By 13%
Nov 03Why Medpace Holdings, Inc. (NASDAQ:MEDP) Could Be Worth Watching
Oct 10Medpace Holdings, Inc. (NASDAQ:MEDP) Shares Could Be 33% Below Their Intrinsic Value Estimate
Sep 26Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 2,776 | 487 | 587 | 635 | 9 |
| 12/31/2025 | 2,418 | 420 | 514 | 559 | 11 |
| 12/31/2024 | 2,141 | 372 | 433 | 472 | 11 |
| 6/30/2024 | 2,030 | 340 | 503 | 540 | N/A |
| 3/31/2024 | 1,963 | 312 | 473 | 506 | N/A |
| 12/31/2023 | 1,886 | 283 | 397 | 433 | N/A |
| 9/30/2023 | 1,782 | 273 | 378 | 414 | N/A |
| 6/30/2023 | 1,673 | 268 | 373 | 408 | N/A |
| 3/31/2023 | 1,563 | 257 | 385 | 422 | N/A |
| 12/31/2022 | 1,460 | 245 | 351 | 388 | N/A |
| 9/30/2022 | 1,374 | 227 | 286 | 322 | N/A |
| 6/30/2022 | 1,286 | 209 | 250 | 286 | N/A |
| 3/31/2022 | 1,213 | 199 | 221 | 252 | N/A |
| 12/31/2021 | 1,142 | 181 | 235 | 263 | N/A |
| 9/30/2021 | 1,094 | 182 | 271 | 298 | N/A |
| 6/30/2021 | 1,028 | 175 | 256 | 285 | N/A |
| 3/31/2021 | 955 | 159 | 235 | 267 | N/A |
| 12/31/2020 | 926 | 145 | 227 | 259 | N/A |
| 9/30/2020 | 896 | 124 | 181 | 210 | N/A |
| 6/30/2020 | 882 | 107 | 188 | 215 | N/A |
| 3/31/2020 | 891 | 110 | 196 | 217 | N/A |
| 12/31/2019 | 861 | 100 | 184 | 202 | N/A |
| 9/30/2019 | 823 | 93 | 169 | 184 | N/A |
| 6/30/2019 | 786 | 88 | 160 | 173 | N/A |
| 3/31/2019 | 742 | 78 | 153 | 167 | N/A |
| 12/31/2018 | 705 | 73 | 141 | 157 | N/A |
| 9/30/2018 | 612 | 61 | 130 | 146 | N/A |
| 6/30/2018 | 531 | 52 | 117 | 132 | N/A |
| 3/31/2018 | 456 | 45 | N/A | 121 | N/A |
| 12/31/2017 | 386 | 39 | N/A | 97 | N/A |
| 9/30/2017 | 382 | 28 | N/A | 98 | N/A |
| 6/30/2017 | 379 | 23 | N/A | 101 | N/A |
| 3/31/2017 | 377 | 18 | N/A | 78 | N/A |
| 12/31/2016 | 371 | 13 | N/A | 92 | N/A |
| 9/30/2016 | 361 | 5 | N/A | 91 | N/A |
| 6/30/2016 | 348 | 0 | N/A | 80 | N/A |
| 3/31/2016 | 332 | -5 | N/A | 94 | N/A |
| 12/31/2015 | 320 | -9 | N/A | 86 | N/A |
| 12/31/2014 | 290 | -16 | N/A | 75 | N/A |
| 12/31/2013 | 244 | 25 | N/A | 98 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: MEDP's forecast earnings growth (13.6% per year) is above the savings rate (2.5%).
Earnings vs Market: MEDP's earnings (13.6% per year) are forecast to grow slower than the US market (15% per year).
High Growth Earnings: MEDP's earnings are forecast to grow, but not significantly.
Revenue vs Market: MEDP's revenue (12.6% per year) is forecast to grow faster than the US market (8.7% per year).
High Growth Revenue: MEDP's revenue (12.6% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: MEDP's Return on Equity is forecast to be high in 3 years time (30.2%)